- May 27, 2021
Bialoom is a deep-tech startup positioned at the crossroads of silicon photonics, biosensors and diagnostics with a mission to support clinicians to analyze acute infections faster, select treatment and monitor disease progression within minutes. Sepsis is a common infection complication that necessitates the analysis of multiple patient biomarkers for effective diagnosis and most importantly for optimized therapy. Despite this need, clinicians lack the point of care diagnostic tool that can effectively detect complicated biomarker “signatures” of infected patients. The need for scalable point of care tests that will be able to meet the growing needs on such densely multiplexed assays is evident and will keep growing with new clinical diagnostic discoveries. Bialoom offers a fully scalable micro-optical detection platform that allows the quantitative analysis of multiple infection-related blood biomarkers from nanoliter blood volumes (1/1000 of a drop) with a single disposable chip. Bialoom’s technology enables a future-ready diagnostic solution for current but also for future densely parallelized diagnostic signatures.